Skip to main content
TipRanks
Go Ultimate75% OFF

Allogene Therapeutics (ALLO) Q4 2024 Earnings Report

1,853 Followers

ALLO Q4 2024 EPS Results

Actual EPS
-$0.28
Consensus EPS
-$0.33
Beat/Miss
Beat by +$0.05
One Year Ago EPS
-$0.51

ALLO Q4 2024 Revenue Results

Actual Revenue
$0
Expected Revenue
$9,000
Beat/Miss
Missed by -$9,000
YoY Revenue Growth
-100.00%

Earnings Announcement Details

Quarter
Q4 2024
Date
03/13/2025
Time
After Close
Conference Call
Thursday, March 13, 2025
ALLO Upcoming Earnings

Allogene Therapeutics's next earnings date is estimated for March 18, 2027, based on past reporting schedules.

Q4 2024 Earnings Call Audio

ALLO Q4 2024 Earnings Call
0:00 / 0:00

Q4 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

ALLO Earnings History

ALLO earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 18, 20272026 (Q4)-0.16--0.17――
Nov 05, 20262026 (Q3)-0.15-0.15-0.1921.05% (+0.04)
Aug 12, 20262026 (Q2)-0.17-0.13-0.2343.48% (+0.10)
May 13, 20262026 (Q1)-0.19-0.18-0.2835.71% (+0.10)
Mar 12, 20262025 (Q4)-0.23-0.17-0.2839.29% (+0.11)
Nov 06, 20252025 (Q3)-0.22-0.19-0.3240.63% (+0.13)
Aug 13, 20252025 (Q2)-0.27-0.23-0.3534.29% (+0.12)
May 13, 20252025 (Q1)-0.29-0.28-0.3826.32% (+0.10)
Mar 13, 20252024 (Q4)-0.33-0.28-0.5145.10% (+0.23)
Nov 07, 20242024 (Q3)-0.33-0.32-0.3713.51% (+0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed